Clinical Trial Watch: Overactive Bladder, BPH

May 15, 2012

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase I-III overactive bladder trials and phase IV BPH trials that are currently recruiting participants. This list is current as of April 19, 2012. For more information, view the complete database at http://ClinicalTrials.gov.

Overactive Bladder

Combined Behavioral and Drug Treatment of Overactive Bladder in MenSponsor(s): University of Alabama at Birmingham
Identifier: NCT01175382

A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With OAB (MK-4618-004)Sponsor(s): Merck
Identifier: NCT01500382

Botox for the Treatment of OAB Secondary to Benign Prostatic ObstructionSponsor(s): Weill Medical College of Cornell University
Identifier: NCT01220726

Refractory OAB: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)Sponsor/Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Duke University; University of Alabama at Birmingham; University of California, San Diego; The Cleveland Clinic; Brown University; University of New Mexico; University of Pennsylvania; University of Pittsburgh; Oregon Health and Science University; RTI International
Identifier: NCT01502956

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic OABSponsor(s): Allergan
Identifier: NCT00439140

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic OAB and Urinary IncontinenceSponsor(s): Allergan
Identifier: NCT01157377

BPH

PROLIEVE Post-Marketing Study Treatment of BPHSponsor(s): Boston Scientific Corporation
Identifier: NCT00407953

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic BPHSponsor/Collaborators: Brooklyn Urology Research Group; American Medical Systems; Richard Wolf Medical Instruments Corporation
Identifier: NCT01500057

An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for BPHSponsor/Collaborators: Weill Medical College of Cornell University; Pfizer
Identifier: NCT00605319